These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 10979074

  • 1. Hyperforin in extracts of St John's wort (Hypericum perforatum) for depression.
    Vormfelde SV, Poser W.
    Arch Intern Med; 2000 Sep 11; 160(16):2548-9. PubMed ID: 10979074
    [No Abstract] [Full Text] [Related]

  • 2. St. John's Wort: is it effective and harmless?
    Biron CR.
    RDH; 1999 Jun 11; 19(6):74-6. PubMed ID: 10895712
    [No Abstract] [Full Text] [Related]

  • 3. St John's Wort and literature quotations.
    Mennini T, Gobbi M, Morazzoni P.
    Arch Intern Med; 2001 Apr 09; 161(7):1016-7. PubMed ID: 11295979
    [No Abstract] [Full Text] [Related]

  • 4. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J, Klejdus B, Kubán V.
    Ceska Slov Farm; 2007 Apr 09; 56(2):62-6. PubMed ID: 17619301
    [Abstract] [Full Text] [Related]

  • 5. St. John's wort.
    Lawvere S, Mahoney MC.
    Am Fam Physician; 2005 Dec 01; 72(11):2249-54. PubMed ID: 16342849
    [Abstract] [Full Text] [Related]

  • 6. St John's wort: Prozac from the plant kingdom.
    Di Carlo G, Borrelli F, Ernst E, Izzo AA.
    Trends Pharmacol Sci; 2001 Jun 01; 22(6):292-7. PubMed ID: 11395157
    [Abstract] [Full Text] [Related]

  • 7. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
    Schempp CM, Winghofer B, Lüdtke R, Simon-Haarhaus B, Schöpf E, Simon JC.
    Br J Dermatol; 2000 May 01; 142(5):979-84. PubMed ID: 10809859
    [Abstract] [Full Text] [Related]

  • 8. Hyperforin analogues from St. John's wort (Hypericum perforatum).
    Verotta L, Appendino G, Jakupovic J, Bombardelli E.
    J Nat Prod; 2000 Mar 01; 63(3):412-5. PubMed ID: 10757735
    [Abstract] [Full Text] [Related]

  • 9. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX, Venkatanarayanan N, Ho CY.
    J Affect Disord; 2017 Mar 01; 210():211-221. PubMed ID: 28064110
    [Abstract] [Full Text] [Related]

  • 10. Determining hyperforin and hypericin content in eight brands of St. John's wort.
    de los Reyes GC, Koda RT.
    Am J Health Syst Pharm; 2002 Mar 15; 59(6):545-7. PubMed ID: 11908248
    [No Abstract] [Full Text] [Related]

  • 11. St. John's wort (Hypericum perforatum) and breastfeeding: plasma and breast milk concentrations of hyperforin for 5 mothers and 2 infants.
    Klier CM, Schmid-Siegel B, Schäfer MR, Lenz G, Saria A, Lee A, Zernig G.
    J Clin Psychiatry; 2006 Feb 15; 67(2):305-9. PubMed ID: 16566628
    [Abstract] [Full Text] [Related]

  • 12. Current St John's wort research from mode of action to clinical efficacy.
    Müller WE.
    Pharmacol Res; 2003 Feb 15; 47(2):101-9. PubMed ID: 12543057
    [Abstract] [Full Text] [Related]

  • 13. Further degradation product of hyperforin from Hypericum perforatum (St John's Wort).
    Vajs V, Vugdelija S, Trifunović S, Karadzić I, Juranić N, Macura S, Milosavljević S.
    Fitoterapia; 2003 Jul 15; 74(5):439-44. PubMed ID: 12837358
    [Abstract] [Full Text] [Related]

  • 14. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W, Schober F, Mannel M.
    Pharmacopsychiatry; 1998 Jun 15; 31 Suppl 1():30-5. PubMed ID: 9684945
    [Abstract] [Full Text] [Related]

  • 15. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort.
    Buchholzer ML, Dvorak C, Chatterjee SS, Klein J.
    J Pharmacol Exp Ther; 2002 May 15; 301(2):714-9. PubMed ID: 11961077
    [Abstract] [Full Text] [Related]

  • 16. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R, Koyabu N, Morimoto S, Shoyama Y, Ohtani H, Sawada Y.
    Drug Metab Dispos; 2005 Apr 15; 33(4):547-54. PubMed ID: 15640377
    [Abstract] [Full Text] [Related]

  • 17. Three new hyperforin analogues from Hypericum perforatum.
    Shan MD, Hu LH, Chen ZL.
    J Nat Prod; 2001 Jan 15; 64(1):127-30. PubMed ID: 11170687
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John's Wort.
    Kiewert C, Buchholzer ML, Hartmann J, Chatterjee SS, Klein J.
    Neurosci Lett; 2004 Jul 08; 364(3):195-8. PubMed ID: 15196674
    [Abstract] [Full Text] [Related]

  • 19. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.
    Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer SA.
    Proc Natl Acad Sci U S A; 2000 Jun 20; 97(13):7500-2. PubMed ID: 10852961
    [Abstract] [Full Text] [Related]

  • 20. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ.
    J Pharm Pharmacol; 2019 Jan 20; 71(1):129-138. PubMed ID: 29411879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.